These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31651200)

  • 61. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.
    Nordgård O; Tjensvoll K; Gilje B; Søreide K
    Br J Surg; 2018 Jan; 105(2):e110-e120. PubMed ID: 29341153
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment.
    Eigeliene N; Saarenheimo J; Jekunen A
    Oncology; 2019; 96(3):115-124. PubMed ID: 30654364
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liquid Biopsies in Colorectal Cancer: Monitoring Genetic Heterogeneity.
    Gargalionis AN; Papavassiliou AG
    Trends Cancer; 2017 Mar; 3(3):166-168. PubMed ID: 28718430
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating tumor DNA and liquid biopsy in oncology.
    Cescon DW; Bratman SV; Chan SM; Siu LL
    Nat Cancer; 2020 Mar; 1(3):276-290. PubMed ID: 35122035
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Possibilities of liquid biopsy in gastric cancer].
    Zakharenko AA; Zaitsev DA; Belyaev MA; Trushin AA; Ten OA; Natkha AS
    Vopr Onkol; 2016; 62(4):379-85. PubMed ID: 30474943
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Liquid biopsy: possibilities and limitations in uro-oncology.
    López-Guerrero JA; Pastor-Navarro B; Claramunt-Alonso R; García-Flores M; Rubio-Briones J
    Arch Esp Urol; 2022 Mar; 75(2):203-214. PubMed ID: 35332890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New cancer blood test developed.
    Burki TK
    Lancet Oncol; 2018 Mar; 19(3):e140. PubMed ID: 29395866
    [No Abstract]   [Full Text] [Related]  

  • 68. Liquid biopsy test appears better at detecting bladder cancer than urine cytology.
    Printz C
    Cancer; 2021 Mar; 127(5):663. PubMed ID: 33605452
    [No Abstract]   [Full Text] [Related]  

  • 69. Liquid Biopsy: General Concepts.
    Poulet G; Massias J; Taly V
    Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Application of circulating tumor DNA in breast cancer.
    Zhao Y; Sheng M; Zheng L; Xiong D; Yang K; Luo Y
    Breast J; 2020 Sep; 26(9):1797-1800. PubMed ID: 32052544
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ultrasensitive Detection of Circulating Tumor DNA in Lymphoma via Targeted Hybridization Capture and Deep Sequencing of Barcoded Libraries.
    Alcaide M; Rushton C; Morin RD
    Methods Mol Biol; 2019; 1956():383-435. PubMed ID: 30779047
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Refining Cancer Management Using Integrated Liquid Biopsy.
    Qiu J; Xu J; Zhang K; Gu W; Nie L; Wang G; Luo Y
    Theranostics; 2020; 10(5):2374-2384. PubMed ID: 32089746
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications.
    Wu S; Li R; Jiang Y; Yu J; Zheng J; Li Z; Li M; Xin K; Wang Y; Xu Z; Li S; Chen X
    Biomed Pharmacother; 2023 Sep; 165():115027. PubMed ID: 37354812
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
    van der Pol Y; Mouliere F
    Cancer Cell; 2019 Oct; 36(4):350-368. PubMed ID: 31614115
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer.
    Li S; Xin K; Pan S; Wang Y; Zheng J; Li Z; Liu X; Liu B; Xu Z; Chen X
    Cell Mol Biol Lett; 2023 Apr; 28(1):28. PubMed ID: 37016296
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker.
    Piao XM; Cha EJ; Yun SJ; Kim WJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567779
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma.
    Wu FT; Lu L; Xu W; Li JY
    Ann Hematol; 2019 Feb; 98(2):255-269. PubMed ID: 30368587
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
    Lopez-Beltran A; Cheng L; Gevaert T; Blanca A; Cimadamore A; Santoni M; Massari F; Scarpelli M; Raspollini MR; Montironi R
    Expert Rev Mol Diagn; 2020 Feb; 20(2):231-243. PubMed ID: 31795775
    [No Abstract]   [Full Text] [Related]  

  • 80. Next-generation sequencing in liquid biopsy: cancer screening and early detection.
    Chen M; Zhao H
    Hum Genomics; 2019 Aug; 13(1):34. PubMed ID: 31370908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.